Home
Storia in 1 fonti
Will Makary's FDA voucher program survive?
RevMed's cancer drug feels out of reach for some, SCOTUS preserves key generic drug pathway, and more biotech news
Raccontata da
statnews.com
Timeline cronologica
- ·
Does Revolution Medicines' pancreatic cancer drug have even greater potential?
Revolution Medicines' pancreatic cancer drug has not yet been approved — and already talk has shifted to how (and when) its use might be expanded.
- ·
Will Makary's FDA voucher program survive?
RevMed's cancer drug feels out of reach for some, SCOTUS preserves key generic drug pathway, and more biotech news